NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.7512
-0.0373 (-4.73%)
At close: Mar 13, 2026, 4:00 PM EDT
0.7700
+0.0188 (2.50%)
After-hours: Mar 13, 2026, 6:36 PM EDT
NMTC Stock Forecast
Stock Price Forecast
The 3 analysts that cover NMTC stock have a consensus rating of "Strong Buy" and an average price target of $1.98, which forecasts a 163.58% increase in the stock price over the next year. The lowest target is $1.45 and the highest is $3.00.
Price Target: $1.98 (+163.58%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NMTC stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $1.5 | Strong Buy | Initiates | $1.5 | +99.68% | Mar 2, 2026 |
| Maxim Group | Maxim Group | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +299.36% | Sep 9, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $1.45 | Strong Buy | Initiates | $1.45 | +93.02% | May 5, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $3.25 → $2.2 | Strong Buy | Maintains | $3.25 → $2.2 | +192.86% | Aug 15, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 28, 2022 |
Financial Forecast
Revenue This Year
11.60M
from 12.10M
Decreased by -4.11%
Revenue Next Year
15.22M
from 11.60M
Increased by 31.17%
EPS This Year
-0.14
from -0.09
EPS Next Year
-0.10
from -0.14
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.9M | 18.1M | |
| Avg | 11.6M | 15.2M | |
| Low | 10.3M | 12.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.2% | 56.0% | |
| Avg | -4.1% | 31.2% | |
| Low | -14.9% | 6.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.13 | -0.08 | |
| Avg | -0.14 | -0.10 | |
| Low | -0.16 | -0.12 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.